Live Breaking News & Updates on Teva Board

Stay updated with breaking news from Teva board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teva Pharma (TEVA) Announces Executive Changes

Teva Pharma (TEVA) Announces Executive Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Richard Francis , Chris Fox , Christine Chris Fox , Sven Dethlefs , Teva Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries , Executive Vice President , North America Commercial , Global President , Gene Therapies , Teva Board , Chief Executive Officer ,

Teva Announces Changes to Executive Management Team

TEL AVIV, Israel & PARSIPPANY, N.J., September 28, 2023 Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and Christine (Chris) Fox, who most recently served as Global President, Gene Therapies at Novartis will be the new head of Teva’s U.S. Commercial Business. "On behalf of the Teva Board of Directors and our executive management team ....

United Kingdom , United States , Christine Chris Fox , Kelley Dougherty , Yonatan Beker , Sven Dethlefs , Christine Fox , Richard Francis , Chris Fox , Sanjeev Sharma , Teva Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries , Executive Vice President , North America Commercial , Global President , Gene Therapies , Teva Board , Chief Executive Officer , Novartis Gene Therapies , Pharmaceutical Industries , Private Securities Litigation Reform Act , Annual Report , Looking Statements , Gene Therapies , Christine Chris Fox , Christine Fox ,